Chris P M Reutelingsperger researcher
Reutelingsperger, Christiaan Peter Maria, 1955-
VIAF ID: 280308965 (Personal)
Permalink: http://viaf.org/viaf/280308965
Preferred Forms
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab |
|
| Annexin A5: an imaging biomarker of cardiovascular risk |
|
| AnnexinA5-pHrodo: a new molecular probe for measuring efferocytosis |
|
| Bringing cell death alive |
|
| Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging |
|
| Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry |
|
| Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance |
|
| Current applications of nanotechnology for magnetic resonance imaging of apoptosis |
|
| Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signalling |
|
| Effects of exogenous recombinant APC in mouse models of ischemia reperfusion injury and of atherosclerosis |
|
| Engineered annexin A5 variants have impaired cell entry for molecular imaging of apoptosis using pretargeting strategies |
|
| Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients |
|
| Extracellular annexin-A1 promotes myeloid/granulocytic differentiation of hematopoietic stem/progenitor cells via the Ca2+/MAPK signalling transduction pathway |
|
| Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization |
|
| Imaging apoptosis for detecting plaque instability: rendering death a brighter facade |
|
| Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes. |
|
| Low human and murine Mcl-1 expression leads to a pro-apoptotic plaque phenotype enriched in giant-cells |
|
| Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction |
|
| Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice |
|
| Nanoparticles for optical molecular imaging of atherosclerosis |
|
| Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure |
|
| Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5 |
|
| Optical and magnetic resonance imaging of cell death and platelet activation using annexin a5-functionalized quantum dots. |
|
| Past, present, and future of annexin A5: from protein discovery to clinical applications. |
|
| Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR-/- Mice on Western Type Diet |
|
| The realm of vitamin K dependent proteins: shifting from coagulation toward calcification. |
|
| Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. |
|
| Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque |
|
| Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions |
|
| Ucma/GRP inhibits phosphate-induced vascular smooth muscle cell calcification via SMAD-dependent BMP signalling. |
|
| Vascular anticoagulant : a new physiological anticoagulant mechanism |
|
| Visualization of cell death in vivo with the annexin A5 imaging protocol |
|
